Association Between Maternal Progesterone Use and Body Weight of Offspring in the US Collaborative Perinatal Project:

Bin Hu1,2, Yuwan Wu1, Qiuling Xie1

  • 1Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

Maternal progesterone use during pregnancy was linked to lower offspring birth weight. This effect persisted for up to a year, especially with longer progesterone exposure.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatric Endocrinology
  • Reproductive Health

Background:

  • Investigating the long-term effects of prenatal medication exposure is crucial for understanding child development.
  • Progesterone is a hormone with critical roles in pregnancy maintenance.

Purpose of the Study:

  • To determine if and how maternal progesterone use during pregnancy affects offspring body weight.
  • To analyze the impact of timing and duration of progesterone use on offspring weight.

Main Methods:

  • Utilized data from the National Collaborative Perinatal Project (1959-1976).
  • Employed multivariable linear regression to assess the association between maternal progesterone use and offspring weight up to age 7.
  • Examined effects based on trimester of initiation, total duration, and pregnancy duration of progesterone use.

Main Results:

  • 1.92% of mothers (952/49,507) used progesterone during pregnancy.
  • Progesterone users' offspring had significantly lower birth weights (-135g) and weights at 4 months (-92.6g) compared to non-users.
  • Lower offspring weight persisted to 1 year for those exposed to progesterone initiated in the second/third trimester or used for over 20 days.

Conclusions:

  • Maternal progesterone use in this historical cohort (1959-1976) is associated with reduced offspring birth weight.
  • Findings suggest a potential impact on offspring growth trajectory.
  • Further contemporary research in diverse populations is recommended.
Abstract